These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 14620887)
1. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women. Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887 [TBL] [Abstract][Full Text] [Related]
2. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen. Hann LE; Gretz EM; Bach AM; Francis SM AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858 [TBL] [Abstract][Full Text] [Related]
3. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen. Lee M; Piao J; Jeon MJ Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174 [TBL] [Abstract][Full Text] [Related]
4. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium. Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435 [TBL] [Abstract][Full Text] [Related]
5. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510 [TBL] [Abstract][Full Text] [Related]
6. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586 [TBL] [Abstract][Full Text] [Related]
7. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen. Schwartz LB; Snyder J; Horan C; Porges RF; Nachtigall LE; Goldstein SR Ultrasound Obstet Gynecol; 1998 Jan; 11(1):48-53. PubMed ID: 9511196 [TBL] [Abstract][Full Text] [Related]
8. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow. Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen. Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477 [TBL] [Abstract][Full Text] [Related]
10. Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen. Elhelw B; Ghorab MN; Farrag SH Int J Gynaecol Obstet; 1999 Nov; 67(2):81-6. PubMed ID: 10636051 [TBL] [Abstract][Full Text] [Related]
11. Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer. Garuti G; Cellani F; Colonnelli M; Garzia D; Gonfiantini C; Luerti M J Am Assoc Gynecol Laparosc; 2004 Feb; 11(1):62-7. PubMed ID: 15104834 [TBL] [Abstract][Full Text] [Related]
12. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy. McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294 [TBL] [Abstract][Full Text] [Related]
13. Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring. Vosse M; Renard F; Coibion M; Neven P; Nogaret JM; Hertens D Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):58-63. PubMed ID: 11803101 [TBL] [Abstract][Full Text] [Related]
14. [Tamoxifen and endometrial pathology]. Negoiţă M; Terinte C; Mihailovici MS Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468 [TBL] [Abstract][Full Text] [Related]
15. The effect of tamoxifen on the endometrium. Uziely B; Lewin A; Brufman G; Dorembus D; Mor-Yosef S Breast Cancer Res Treat; 1993; 26(1):101-5. PubMed ID: 8400318 [TBL] [Abstract][Full Text] [Related]
16. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP Menopause; 2009; 16(2):293-300. PubMed ID: 19034048 [TBL] [Abstract][Full Text] [Related]
17. [Ultrasound endometrium follow-up during tamoxifen treatment: Really not reliable or useful after all?]. Burkart C; Wight E; Pók J; Kernen B; Traber M; Haller U; Bajka M Ultraschall Med; 2001 Jun; 22(3):136-42. PubMed ID: 11484445 [TBL] [Abstract][Full Text] [Related]
18. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen. Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703 [TBL] [Abstract][Full Text] [Related]
19. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen. Cohen I Gynecol Oncol; 2001 Aug; 82(2):406-7. PubMed ID: 11531305 [No Abstract] [Full Text] [Related]
20. Usefulness of saline infusion sonohysterography and feeding artery imaging in endometrial polyp diagnosis. Anioł M; Dec G; Wojda K; Sieroszewski P Ginekol Pol; 2017; 88(6):285-288. PubMed ID: 28727125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]